ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET


AstraZeneca PLC.
448 announcements.
Time Date Ticker Company Announcement
16:00 09-09-2021 AZN AstraZeneca PLC
Imfinzi improves survival in NSCLC in POSEIDON
07:00 09-09-2021 AZN AstraZeneca PLC
PT027 PhIII asthma trials met primary endpoints
07:00 03-09-2021 AZN AstraZeneca PLC
Ultomiris approved in EU for children with PNH
15:00 01-09-2021 AZN AstraZeneca PLC
Total Voting Rights
07:05 26-08-2021 AZN AstraZeneca PLC
Forxiga approved in Japan for CKD
07:00 26-08-2021 AZN AstraZeneca PLC
ALXN1840 Wilson Phase III met primary endpoint
07:05 20-08-2021 AZN AstraZeneca PLC
Update on Ultomiris Phase III ALS trial
07:00 20-08-2021 AZN AstraZeneca PLC
AZD7442 prophylaxis trial met primary endpoint
15:00 16-08-2021 AZN AstraZeneca PLC
Director/PDMR Shareholding
14:35 11-08-2021 AZN AstraZeneca PLC
Update on US review of roxadustat
07:05 09-08-2021 AZN AstraZeneca PLC
Forxiga approved in the EU for CKD
07:00 09-08-2021 AZN AstraZeneca PLC
Enhertu head-to-head trial meets primary endpoint
15:00 02-08-2021 AZN AstraZeneca PLC
Total Voting Rights
07:00 02-08-2021 AZN AstraZeneca PLC
Saphnelo approved in the US for SLE
07:00 29-07-2021 AZN AstraZeneca PLC
AZN: H1 2021 Results
07:00 26-07-2021 AZN AstraZeneca PLC
Ultomiris recommended in EU for children with PNH
07:00 22-07-2021 AZN AstraZeneca PLC
Directorate Change
15:56 21-07-2021 AZN AstraZeneca PLC
Director/PDMR Shareholding
15:45 21-07-2021 AZN AstraZeneca PLC
Total Voting Rights
13:45 21-07-2021 AZN AstraZeneca PLC
Acquisition of Alexion completed
07:00 19-07-2021 AZN AstraZeneca PLC
Imfinzi approved in China for extensive-stage SCLC
07:00 16-07-2021 AZN AstraZeneca PLC
Status on US FDA Advisory Committee for roxadustat
07:08 14-07-2021 AZN AstraZeneca PLC
AstraZeneca-Alexion transaction cleared in the UK
07:00 08-07-2021 AZN AstraZeneca PLC
Tezepelumab granted FDA Priority Review for asthma
07:00 06-07-2021 AZN AstraZeneca PLC
AstraZeneca-Alexion transaction cleared in the EU
15:00 01-07-2021 AZN AstraZeneca PLC
Total Voting Rights
07:05 28-06-2021 AZN AstraZeneca PLC
Forxiga recommended in EU for patients with CKD
07:00 28-06-2021 AZN AstraZeneca PLC
Nirsevimab PhII/III trial confirms safety profile
07:00 24-06-2021 AZN AstraZeneca PLC
Lynparza approved in China for prostate cancer
07:00 23-06-2021 AZN AstraZeneca PLC
Orpathys approved in China for lung cancer
07:00 22-06-2021 AZN AstraZeneca PLC
Koselugo approved in the EU for children with NF1
07:00 15-06-2021 AZN AstraZeneca PLC
Update on AZD7442 STORM CHASER trial
07:00 07-06-2021 AZN AstraZeneca PLC
Calquence head-to-head results versus ibrutinib
07:05 04-06-2021 AZN AstraZeneca PLC
Lynparza reduced recurrence risk in breast cancer
07:00 04-06-2021 AZN AstraZeneca PLC
AstraZeneca appoints new Chief Financial Officer
07:00 02-06-2021 AZN AstraZeneca PLC
Publication of Final Terms
15:01 01-06-2021 AZN AstraZeneca PLC
Block listing Interim Review
15:00 01-06-2021 AZN AstraZeneca PLC
Total Voting Rights
07:00 28-05-2021 AZN AstraZeneca PLC
Tagrisso approved in EU in early lung cancer
16:41 27-05-2021 AZN AstraZeneca PLC
Second Price Monitoring Extn
16:36 27-05-2021 AZN AstraZeneca PLC
Price Monitoring Extension
07:00 27-05-2021 AZN AstraZeneca PLC
AstraZeneca prices a EUR800m bond offering
07:00 26-05-2021 AZN AstraZeneca PLC
AstraZeneca prices a $7bn bond offering
07:00 25-05-2021 AZN AstraZeneca PLC
EMTN programme update - publication of Prospectus
07:00 21-05-2021 AZN AstraZeneca PLC
Vaxzevria COVID-19 vaccine approved in Japan
15:30 18-05-2021 AZN AstraZeneca PLC
Director/PDMR Shareholding
14:00 11-05-2021 AZN AstraZeneca PLC
Result of AGM
13:55 11-05-2021 AZN AstraZeneca PLC
Shareholders vote in favour of Alexion acquisition
07:00 07-05-2021 AZN AstraZeneca PLC
Imfinzi + tremelimumab showed survival in POSEIDON
15:00 04-05-2021 AZN AstraZeneca PLC
Total Voting Rights
07:00 04-05-2021 AZN AstraZeneca PLC
Farxiga approved in the US for CKD
07:00 30-04-2021 AZN AstraZeneca PLC
AZN: First quarter 2021 results
07:10 26-04-2021 AZN AstraZeneca PLC
Selumetinib recommended for EU approval in NF1
07:05 26-04-2021 AZN AstraZeneca PLC
Tagrisso adjuvant receives positive CHMP opinion
07:00 26-04-2021 AZN AstraZeneca PLC
Nirsevimab Phase III trial met primary endpoint
12:00 16-04-2021 AZN AstraZeneca PLC
US clearance of proposed acquisition of Alexion
07:00 14-04-2021 AZN AstraZeneca PLC
Tagrisso approved in China in early lung cancer
13:00 12-04-2021 AZN AstraZeneca PLC
Circular and notice of general meeting
07:00 12-04-2021 AZN AstraZeneca PLC
Update on Farxiga COVID-19 DARE-19 Phase III trial
15:00 01-04-2021 AZN AstraZeneca PLC
Total Voting Rights
12:15 30-03-2021 AZN AstraZeneca PLC
Notice of AGM
15:00 25-03-2021 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 25-03-2021 AZN AstraZeneca PLC
AZD1222 US Ph3 primary analysis confirms efficacy
07:00 22-03-2021 AZN AstraZeneca PLC
AstraZeneca US vaccine trial met primary endpoint
07:05 16-03-2021 AZN AstraZeneca PLC
Divestment of Viela shareholding completed
07:00 16-03-2021 AZN AstraZeneca PLC
US supply agreement for additional AZD7442 doses
15:00 09-03-2021 AZN AstraZeneca PLC
Director/PDMR Shareholding
15:00 04-03-2021 AZN AstraZeneca PLC
Designation of EU home member state
07:00 03-03-2021 AZN AstraZeneca PLC
US court decision favours Symbicort patents
07:00 02-03-2021 AZN AstraZeneca PLC
Further update on roxadustat US regulatory review
15:00 01-03-2021 AZN AstraZeneca PLC
Total Voting Rights
07:00 22-02-2021 AZN AstraZeneca PLC
Voluntary withdrawal Imfinzi US bladder indication
07:00 17-02-2021 AZN AstraZeneca PLC
Lynparza: IDMC recommend early analysis of OlympiA
11:15 16-02-2021 AZN AstraZeneca PLC
Filing of Form 20-F with SEC
15:00 15-02-2021 AZN AstraZeneca PLC
Director/PDMR Shareholding
11:00 15-02-2021 AZN AstraZeneca PLC
Annual Financial Report
07:01 11-02-2021 AZN AstraZeneca PLC
AstraZeneca Non-Executive Board changes
07:00 11-02-2021 AZN AstraZeneca PLC
AZN: full-year 2020 results
07:00 10-02-2021 AZN AstraZeneca PLC
Divestment of Crestor in Europe completed
07:00 05-02-2021 AZN AstraZeneca PLC
Update on KESTREL Phase III trial for Imfinzi
07:00 04-02-2021 AZN AstraZeneca PLC
Forxiga approved in China for heart failure
15:00 01-02-2021 AZN AstraZeneca PLC
Total Voting Rights
12:15 01-02-2021 AZN AstraZeneca PLC
AstraZeneca agrees to divest Viela shareholding
07:00 01-02-2021 AZN AstraZeneca PLC
COVID-19 vaccine authorised for use by the EU
15:16 29-01-2021 AZN AstraZeneca PLC
COVID-19 vaccine receives positive opinion in EU
15:00 26-01-2021 AZN AstraZeneca PLC
Block listing application
07:00 26-01-2021 AZN AstraZeneca PLC
Symbicort approved in China for mild asthma
07:05 25-01-2021 AZN AstraZeneca PLC
Calquence approved in Japan for CLL
07:00 25-01-2021 AZN AstraZeneca PLC
Calquence met primary endpoint against ibrutinib
07:00 20-01-2021 AZN AstraZeneca PLC
Enhertu approved in the EU for breast cancer
07:00 18-01-2021 AZN AstraZeneca PLC
Enhertu approved in the US for gastric cancer
07:00 15-01-2021 AZN AstraZeneca PLC
Imfinzi new dosing approved in EU
07:00 06-01-2021 AZN AstraZeneca PLC
Farxiga granted US Priority Review for CKD
15:00 04-01-2021 AZN AstraZeneca PLC
Total Voting Rights
07:00 04-01-2021 AZN AstraZeneca PLC
Atacand divestment in over 70 countries completed
07:00 30-12-2020 AZN AstraZeneca PLC
AstraZenecas COVID-19 vaccine authorised in UK
07:00 29-12-2020 AZN AstraZeneca PLC
Lynparza approved in Japan for three cancers
07:05 21-12-2020 AZN AstraZeneca PLC
Tagrisso approved in the US for early lung cancer
07:00 21-12-2020 AZN AstraZeneca PLC
Update on US regulatory review of roxadustat
16:00 17-12-2020 AZN AstraZeneca PLC
Director/PDMR Shareholding
18:15 16-12-2020 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 15-12-2020 AZN AstraZeneca PLC
Imfinzi new dose receives positive EU CHMP opinion
07:05 14-12-2020 AZN AstraZeneca PLC
Trastuzumab deruxtecan positive CHMP
07:00 14-12-2020 AZN AstraZeneca PLC
Trixeo Aerosphere approved in the EU for COPD
07:00 14-12-2020 AZN AstraZeneca PLC
AstraZeneca to acquire Alexion Pharmaceuticals Inc
15:00 01-12-2020 AZN AstraZeneca PLC
Block listing Interim Review
15:00 01-12-2020 AZN AstraZeneca PLC
Total Voting Rights
07:00 01-12-2020 AZN AstraZeneca PLC
Crestor to be divested to Grnenthal in Europe
07:00 30-11-2020 AZN AstraZeneca PLC
Forxiga approved in Japan for heart failure
07:00 23-11-2020 AZN AstraZeneca PLC
AZD1222 vaccine effective against COVID-19
07:00 20-11-2020 AZN AstraZeneca PLC
Imfinzi new dosing approved in the US
07:00 10-11-2020 AZN AstraZeneca PLC
Tezepelumab Phase III trial met primary endpoint
07:00 09-11-2020 AZN AstraZeneca PLC
Calquence approved in the EU for CLL
07:00 06-11-2020 AZN AstraZeneca PLC
Brilinta approved in the US in stroke
07:15 05-11-2020 AZN AstraZeneca PLC
Lynparza approved in the EU for wider ovarian use
07:10 05-11-2020 AZN AstraZeneca PLC
Lynparza approved in the EU for prostate cancer
07:05 05-11-2020 AZN AstraZeneca PLC
Forxiga approved in the EU for heart failure
07:00 05-11-2020 AZN AstraZeneca PLC
AZN: Year-to-date and Q3 2020 results
15:00 02-11-2020 AZN AstraZeneca PLC
Total Voting Rights
07:00 30-10-2020 AZN AstraZeneca PLC
Atacand to be divested in more than 70 countries
07:00 29-10-2020 AZN AstraZeneca PLC
Directorate Change
07:03 28-10-2020 AZN AstraZeneca PLC
Enhertu US Priority Review in gastric cancer
07:00 28-10-2020 AZN AstraZeneca PLC
Forxiga CV outcomes benefit approved in China
07:00 20-10-2020 AZN AstraZeneca PLC
Tagrisso adjuvant lung cancer US Priority Review
07:00 19-10-2020 AZN AstraZeneca PLC
Forxiga HF receives positive CHMP opinion
07:00 19-10-2020 AZN AstraZeneca PLC
Trixeo Aerosphere receives positive CHMP opinion
07:00 12-10-2020 AZN AstraZeneca PLC
COVID-19 antibodies advance and get US funding
07:00 02-10-2020 AZN AstraZeneca PLC
Farxiga granted US BTD in chronic kidney disease
15:00 01-10-2020 AZN AstraZeneca PLC
Total Voting Rights
07:00 25-09-2020 AZN AstraZeneca PLC
Directorate Change
07:05 21-09-2020 AZN AstraZeneca PLC
Lynparza EU recommendation in prostate cancer
07:00 21-09-2020 AZN AstraZeneca PLC
Lynparza EU recommendation in ovarian cancer
07:00 21-09-2020 AZN AstraZeneca PLC
Tagrisso reduced early lung cancer brain recurrenc
07:01 10-09-2020 AZN AstraZeneca PLC
AstraZeneca to list all US securities on Nasdaq
07:00 10-09-2020 AZN AstraZeneca PLC
Fasenra PhIII OSTRO trial met co-primary endpoints
15:00 01-09-2020 AZN AstraZeneca PLC
Total Voting Rights
07:00 01-09-2020 AZN AstraZeneca PLC
Imfinzi approved in EU for small cell lung cancer
07:00 01-09-2020 AZN AstraZeneca PLC
Farxiga reduces CKD progression and risk of death
07:00 25-08-2020 AZN AstraZeneca PLC
Ph I trial begins for COVID-19 monoclonal antibody
07:00 21-08-2020 AZN AstraZeneca PLC
Imfinzi approved in Japan for SCLC
07:00 18-08-2020 AZN AstraZeneca PLC
Imfinzi US Priority Review; four-week, fixed dose
07:00 04-08-2020 AZN AstraZeneca PLC
AstraZeneca prices a $3bn bond issue
15:00 03-08-2020 AZN AstraZeneca PLC
Total Voting Rights
07:25 30-07-2020 AZN AstraZeneca PLC
Tagrisso US BTD for EGFRm adjuvant lung cancer
07:18 30-07-2020 AZN AstraZeneca PLC
AZN: H1 2020 results
07:00 29-07-2020 AZN AstraZeneca PLC
Board Committee Changes
07:00 28-07-2020 AZN AstraZeneca PLC
Farxiga DAPA-CKD trial met all endpoints
07:10 27-07-2020 AZN AstraZeneca PLC
Calquence receives positive CHMP opinion for CLL
07:05 27-07-2020 AZN AstraZeneca PLC
Imfinzi recommended for EU approval in SCLC
07:00 27-07-2020 AZN AstraZeneca PLC
AstraZeneca enters collaboration in oncology
07:00 24-07-2020 AZN AstraZeneca PLC
Breztri Aerosphere approved in the US for COPD
15:00 22-07-2020 AZN AstraZeneca PLC
Holding(s) in Company
15:00 22-07-2020 AZN AstraZeneca PLC
Holding(s) in Company
15:00 21-07-2020 AZN AstraZeneca PLC
Holding(s) in Company
15:00 21-07-2020 AZN AstraZeneca PLC
Holding(s) in Company
14:41 20-07-2020 AZN AstraZeneca PLC
COVID-19 vaccine Phase I/II showed immune response
07:00 16-07-2020 AZN AstraZeneca PLC
Director Declaration
07:00 09-07-2020 AZN AstraZeneca PLC
Brilinta granted US FDA Priority Review for stroke
07:00 08-07-2020 AZN AstraZeneca PLC
Lynparza approved in the EU for pancreatic cancer
15:00 01-07-2020 AZN AstraZeneca PLC
Total Voting Rights
15:00 30-06-2020 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 30-06-2020 AZN AstraZeneca PLC
Selumetinib granted Japan orphan drug designation
15:03 17-06-2020 AZN AstraZeneca PLC
Holding(s) in Company
15:00 17-06-2020 AZN AstraZeneca PLC
Holding(s) in Company
07:00 15-06-2020 AZN AstraZeneca PLC
Agreement to Supply Europe with COVID-19 Vaccine
07:00 11-06-2020 AZN AstraZeneca PLC
EMTN Programme Routine Technical Update
15:00 01-06-2020 AZN AstraZeneca PLC
Block listing Interim Review
15:00 01-06-2020 AZN AstraZeneca PLC
Total Voting Rights
07:00 01-06-2020 AZN AstraZeneca PLC
Brilinta obtains additional US approval
07:00 01-06-2020 AZN AstraZeneca PLC
Lynparza EU CHMP opinion in pancreatic cancer
16:41 29-05-2020 AZN AstraZeneca PLC
Second Price Monitoring Extn
16:35 29-05-2020 AZN AstraZeneca PLC
Price Monitoring Extension
13:00 29-05-2020 AZN AstraZeneca PLC
Imfinzi sustained overall survival in CASPIAN
13:00 29-05-2020 AZN AstraZeneca PLC
Enhertu DESTINY-Gastric01 results from ASCO 2020
07:00 29-05-2020 AZN AstraZeneca PLC
Tagrisso unprecedented adjuvant lung cancer data
10:30 26-05-2020 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 22-05-2020 AZN AstraZeneca PLC
Enhertu US orphan designation in gastric cancer
07:00 21-05-2020 AZN AstraZeneca PLC
AstraZeneca advances response to COVID-19 outbreak
07:00 20-05-2020 AZN AstraZeneca PLC
Lynparza approved in the US for prostate cancer
07:00 18-05-2020 AZN AstraZeneca PLC
Enhertu US Breakthrough status for lung cancer
07:00 18-05-2020 AZN AstraZeneca PLC
Bevespi Aerosphere approved in China for COPD
07:00 11-05-2020 AZN AstraZeneca PLC
Enhertu designated gastric cancer BTD
07:00 11-05-2020 AZN AstraZeneca PLC
Lynparza gets broader US ovarian cancer approval
07:00 11-05-2020 AZN AstraZeneca PLC
Brazikumab rights recovered by AstraZeneca
07:00 06-05-2020 AZN AstraZeneca PLC
Farxiga approved by FDA for heart failure (HFrEF)
15:00 01-05-2020 AZN AstraZeneca PLC
Total Voting Rights
16:00 29-04-2020 AZN AstraZeneca PLC
Result of AGM
07:00 29-04-2020 AZN AstraZeneca PLC
AZN: first-quarter 2020 results
07:00 24-04-2020 AZN AstraZeneca PLC
Lynparza shows overall survival in prostate cancer
11:00 17-04-2020 AZN AstraZeneca PLC
Changes to arrangements for AGM
07:00 14-04-2020 AZN AstraZeneca PLC
Koselugo (selumetinib) approved in the US for NF1
07:00 14-04-2020 AZN AstraZeneca PLC
Tagrisso adjuvant trial overwhelmingly positive
07:00 02-04-2020 AZN AstraZeneca PLC
AstraZeneca divestment of Movantik completed
15:00 01-04-2020 AZN AstraZeneca PLC
Total Voting Rights
07:00 31-03-2020 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:01 30-03-2020 AZN AstraZeneca PLC
Imfinzi approved in US for small cell lung cancer
07:00 30-03-2020 AZN AstraZeneca PLC
Farxiga CKD trial early stop for positive efficacy
07:00 26-03-2020 AZN AstraZeneca PLC
Lokelma approved in Japan for hyperkalaemia
07:00 26-03-2020 AZN AstraZeneca PLC
Director/PDMR Shareholding
16:41 24-03-2020 AZN AstraZeneca PLC
Second Price Monitoring Extn
16:36 24-03-2020 AZN AstraZeneca PLC
Price Monitoring Extension
12:02 24-03-2020 AZN AstraZeneca PLC
Price Monitoring Extension
16:40 23-03-2020 AZN AstraZeneca PLC
Second Price Monitoring Extn
16:36 23-03-2020 AZN AstraZeneca PLC
Price Monitoring Extension
12:08 23-03-2020 AZN AstraZeneca PLC
Second Price Monitoring Extn
12:03 23-03-2020 AZN AstraZeneca PLC
Price Monitoring Extension
10:20 20-03-2020 AZN AstraZeneca PLC
Second Price Monitoring Extn
10:15 20-03-2020 AZN AstraZeneca PLC
Price Monitoring Extension
07:00 20-03-2020 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 19-03-2020 AZN AstraZeneca PLC
Lynparza granted orphan drug designation in Japan
07:00 17-03-2020 AZN AstraZeneca PLC
Imfinzi confirmed overall survival in CASPIAN
16:35 13-03-2020 AZN AstraZeneca PLC
Price Monitoring Extension
11:00 12-03-2020 AZN AstraZeneca PLC
Notice of AGM
07:00 12-03-2020 AZN AstraZeneca PLC
Update on Phase III GY004 trial for cediranib
07:00 10-03-2020 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 06-03-2020 AZN AstraZeneca PLC
Update on Phase III DANUBE trial in bladder cancer
07:00 04-03-2020 AZN AstraZeneca PLC
Filing of Form 20-F with SEC
11:00 03-03-2020 AZN AstraZeneca PLC
Annual Financial Report
15:00 02-03-2020 AZN AstraZeneca PLC
Total Voting Rights
07:00 02-03-2020 AZN AstraZeneca PLC
Divestment of hypertension medicines completed
07:00 27-02-2020 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 25-02-2020 AZN AstraZeneca PLC
AstraZeneca divests global rights to Movantik
07:00 19-02-2020 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 19-02-2020 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 14-02-2020 AZN AstraZeneca PLC
AZN: Full-year and Q4 2019 results
15:00 03-02-2020 AZN AstraZeneca PLC
Total Voting Rights
07:00 27-01-2020 AZN AstraZeneca PLC
AstraZeneca divests hypertension medicines
07:00 27-01-2020 AZN AstraZeneca PLC
Brilinta met primary endpoint in stroke trial
07:00 27-01-2020 AZN AstraZeneca PLC
AstraZeneca to recover brazikumab (MEDI2070)
07:00 27-01-2020 AZN AstraZeneca PLC
Enhertu Phase II trial met primary endpoint
07:00 20-01-2020 AZN AstraZeneca PLC
FDA grants Lynparza Priority Review for PROfound
07:00 20-01-2020 AZN AstraZeneca PLC
Imfinzi, tremelimumab granted ODD in liver cancer
07:01 13-01-2020 AZN AstraZeneca PLC
Lynparza granted FDA Priority Review for PAOLA-1
07:00 13-01-2020 AZN AstraZeneca PLC
Update on Epanova Phase III STRENGTH trial
07:00 06-01-2020 AZN AstraZeneca PLC
Lokelma approved in China for hyperkalaemia
07:01 06-01-2020 AZN AstraZeneca PLC
Farxiga granted FDA heart failure Priority Review
15:00 02-01-2020 AZN AstraZeneca PLC
Total Voting Rights
07:00 30-12-2019 AZN AstraZeneca PLC
US FDA approved Lynparza for pancreatic cancer
07:00 23-12-2019 AZN AstraZeneca PLC
Enhertu (trastuzumab deruxtecan) approved in US
07:00 23-12-2019 AZN AstraZeneca PLC
Triple-combination approved in China for COPD
07:00 20-12-2019 AZN AstraZeneca PLC
AstraZeneca divests rights to Arimidex and Casodex
07:00 16-12-2019 AZN AstraZeneca PLC
Seroquel rights agreement complete: Europe, Russia
07:00 12-12-2019 AZN AstraZeneca PLC
Imfinzi approved in China for Stage III NSCLC
13:00 11-12-2019 AZN AstraZeneca PLC
Trastuzumab deruxtecan achieves ORR of 60.9%
07:00 05-12-2019 AZN AstraZeneca PLC
Lynparza approved in China for 1L BRCAm ovarian
07:00 03-12-2019 AZN AstraZeneca PLC
AstraZeneca divests Seroquel rights: US and Canada
15:00 02-12-2019 AZN AstraZeneca PLC
Block listing Interim Review
15:00 02-12-2019 AZN AstraZeneca PLC
Total Voting Rights
07:00 29-11-2019 AZN AstraZeneca PLC
Imfinzi granted FDA Priority Review for SCLC
07:00 15-11-2019 AZN AstraZeneca PLC
Qtrilmet approved in the EU for treatment of T2D
07:00 14-11-2019 AZN AstraZeneca PLC
FDA accepts regulatory submission for selumetinib
07:00 12-11-2019 AZN AstraZeneca PLC
Anifrolumab demonstrated superiority in TULIP 2
07:00 11-11-2019 AZN AstraZeneca PLC
Roxadustat pooled analyses: no increased CV risk
07:00 08-11-2019 AZN AstraZeneca PLC
Roxadustat significantly increased haemoglobin
14:10 06-11-2019 AZN AstraZeneca PLC
Calquence data to show improved progression-free
15:00 01-11-2019 AZN AstraZeneca PLC
Total Voting Rights
07:00 30-10-2019 AZN AstraZeneca PLC
AstraZeneca divests rights to Seroquel and
15:31 28-10-2019 AZN AstraZeneca PLC
Imfinzi and Imfinzi plus tremelimumab delayed
07:00 24-10-2019 AZN AstraZeneca PLC
AstraZeneca year-to-date and Q3 2019 results
07:00 21-10-2019 AZN AstraZeneca PLC
Farxiga approved in the US to reduce the risk of
07:00 17-10-2019 AZN AstraZeneca PLC
Trastuzumab deruxtecan granted FDA Priority Review
15:04 04-10-2019 AZN AstraZeneca PLC
Holding(s) in Company
15:00 04-10-2019 AZN AstraZeneca PLC
Holding(s) in Company
07:00 04-10-2019 AZN AstraZeneca PLC
Fasenra approved in the US for self-administration
16:00 03-10-2019 AZN AstraZeneca PLC
Director Declaration
15:00 01-10-2019 AZN AstraZeneca PLC
Total Voting Rights
07:05 01-10-2019 AZN AstraZeneca PLC
AstraZeneca divests rights for Losec to Cheplaphar
07:00 01-10-2019 AZN AstraZeneca PLC
Update on US regulatory review of PT010 in COPD
15:30 30-09-2019 AZN AstraZeneca PLC
Lynparza more than doubled the time without
07:00 30-09-2019 AZN AstraZeneca PLC
Tagrisso is the only 1st-line treatment for EGFR-
07:00 30-09-2019 AZN AstraZeneca PLC
Lynparza improved the time women lived without
07:00 23-09-2019 AZN AstraZeneca PLC
Qtrilmet recommended for approval in EU by CHMP
07:00 18-09-2019 AZN AstraZeneca PLC
AstraZeneca amends collaboration with Ironwood
08:38 09-09-2019 AZN AstraZeneca PLC
Imfinzi is first immunotherapy to show both
07:11 04-09-2019 AZN AstraZeneca PLC
Tagrisso approved in China as a 1st-line treatment
15:00 02-09-2019 AZN AstraZeneca PLC
Total Voting Rights
07:05 02-09-2019 AZN AstraZeneca PLC
Brilinta reduced the risk of cardiovascular events
07:00 02-09-2019 AZN AstraZeneca PLC
Detailed results from Phase III DAPA-HF trial
07:00 29-08-2019 AZN AstraZeneca PLC
Anifrolumab Phase III trial meets primary endpoint
07:05 28-08-2019 AZN AstraZeneca PLC
Fasenra granted US Orphan Drug Designation for
07:00 28-08-2019 AZN AstraZeneca PLC
Breztri Aerosphere Phase III ETHOS trial met
07:00 22-08-2019 AZN AstraZeneca PLC
AstraZeneca agrees to buy US FDA Priority Review
07:00 22-08-2019 AZN AstraZeneca PLC
Roxadustat approved in China for the treatment of
07:00 21-08-2019 AZN AstraZeneca PLC
Update on the Phase III NEPTUNE trial
07:00 20-08-2019 AZN AstraZeneca PLC
Farxiga met primary endpoint in landmark Phase III
07:00 19-08-2019 AZN AstraZeneca PLC
Directorate Change
07:00 14-08-2019 AZN AstraZeneca PLC
Lynparza Phase III PAOLA-1 trial met primary endpo
07:00 14-08-2019 AZN AstraZeneca PLC
Calquence granted US Breakthrough Therapy Designat
09:28 09-08-2019 AZN AstraZeneca PLC
Amendment: Tagrisso significantly improves overall
07:00 09-08-2019 AZN AstraZeneca PLC
Tagrisso significantly improves overall survival
07:00 07-08-2019 AZN AstraZeneca PLC
Lynparza Phase III PROfound trial in HRR*
07:00 05-08-2019 AZN AstraZeneca PLC
Forxiga label updated in the EU in type-2 diabetes
15:00 01-08-2019 AZN AstraZeneca PLC
Total Voting Rights
07:00 25-07-2019 AZN AstraZeneca PLC
AZN: H1 2019 Results
07:00 15-07-2019 AZN AstraZeneca PLC
Update on US regulatory decision for Farxiga
07:00 12-07-2019 AZN AstraZeneca PLC
Imfinzi granted US Orphan Drug Designation for
15:00 01-07-2019 AZN AstraZeneca PLC
Total Voting Rights
07:00 01-07-2019 AZN AstraZeneca PLC
Fasenra receives positive EU CHMP opinion for self
07:00 01-07-2019 AZN AstraZeneca PLC
Forxiga receives positive EU CHMP opinion for
07:00 27-06-2019 AZN AstraZeneca PLC
Imfinzi improves overall survival at interim
07:00 19-06-2019 AZN AstraZeneca PLC
Lynparza approved in Japan for 1st-line
07:00 19-06-2019 AZN AstraZeneca PLC
Breztri Aerosphere (PT010) approved in Japan for
07:00 19-06-2019 AZN AstraZeneca PLC
Bevespi Aerosphere approved by the Japanese
07:00 18-06-2019 AZN AstraZeneca PLC
Lynparza approved in the EU for 1st-line
07:00 17-06-2019 AZN AstraZeneca PLC
Calquence significantly prolonged the time patient
16:45 12-06-2019 AZN AstraZeneca PLC
Publication of a Prospectus
07:00 06-06-2019 AZN AstraZeneca PLC
Calquence Phase III ELEVATE-TN trial met primary
12:36 05-06-2019 AZN Hardman & Co Research
AstraZeneca: Where has all the cash gone?
15:00 03-06-2019 AZN AstraZeneca PLC
Total Voting Rights
15:00 03-06-2019 AZN AstraZeneca PLC
Block listing Interim Review
07:00 03-06-2019 AZN AstraZeneca PLC
Lynparza nearly doubled time patients lived with
07:00 10-05-2019 AZN AstraZeneca PLC
Pooled analyses of the roxadustat global Phase III
14:00 08-05-2019 AZN AstraZeneca PLC
Director/PDMR Shareholding
11:00 08-05-2019 AZN AstraZeneca PLC
Director Declaration
07:00 08-05-2019 AZN AstraZeneca PLC
Trastuzumab deruxtecan demonstrated clinically
07:00 07-05-2019 AZN AstraZeneca PLC
Calquence PhIII ASCEND trial met primary endpoint
07:00 03-05-2019 AZN AstraZeneca PLC
Qternmet XR approved in the US for type-2 diabetes
15:00 01-05-2019 AZN AstraZeneca PLC
Total Voting Rights
12:00 01-05-2019 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 29-04-2019 AZN AstraZeneca PLC
Lynparza receives positive EU CHMP opinion for 1st
07:00 26-04-2019 AZN AstraZeneca PLC
AZN: Q1 2019 Results
07:00 10-04-2019 AZN AstraZeneca PLC
Lynparza approved in EU for the treatment of germl
13:30 04-04-2019 AZN AstraZeneca PLC
Holding(s) in Company
10:00 03-04-2019 AZN AstraZeneca PLC
Director/PDMR Shareholding
15:00 02-04-2019 AZN AstraZeneca PLC
Total Voting Rights
15:00 01-04-2019 AZN AstraZeneca PLC
Total Voting Rights
07:00 01-04-2019 AZN AstraZeneca PLC
Selumetinib gets Breakthrough Therapy Designation
17:15 29-03-2019 AZN AstraZeneca PLC
Results of Placing
07:00 29-03-2019 AZN AstraZeneca PLC
AZ and Daiichi Sankyo enter collaboration in novel
07:00 29-03-2019 AZN AstraZeneca PLC
Proposed placing of new ordinary shares
07:00 27-03-2019 AZN AstraZeneca PLC
Forxiga approved in Japan for type-1 diabetes
07:00 25-03-2019 AZN AstraZeneca PLC
Forxiga approved in Europe for type-1 diabetes
07:00 18-03-2019 AZN AstraZeneca PLC
US FDA grants saracatinib ODD for IPF
12:00 14-03-2019 AZN AstraZeneca PLC
Notice of AGM
12:00 12-03-2019 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 06-03-2019 AZN AstraZeneca PLC
Filing of Form 20-F with SEC
11:00 05-03-2019 AZN AstraZeneca PLC
Annual Financial Report
15:00 01-03-2019 AZN AstraZeneca PLC
Total Voting Rights
13:45 01-03-2019 AZN AstraZeneca PLC
Lynparza receives positive EU CHMP opinion
07:00 26-02-2019 AZN AstraZeneca PLC
Lynparza significantly delayed disease progression
07:00 25-02-2019 AZN AstraZeneca PLC
Brilinta's PhIII THEMIS trial met primary endpoint
07:00 14-02-2019 AZN AstraZeneca PLC
AstraZeneca Full-Year and Q4 2018 Results
07:00 06-02-2019 AZN AstraZeneca PLC
US FDA grants Fasenra Orphan Drug Designation
07:05 05-02-2019 AZN AstraZeneca PLC
US FDA grants Breakthrough Therapy Designation
07:00 05-02-2019 AZN AstraZeneca PLC
EMA grants PRIME eligibility for MEDI8897
15:00 01-02-2019 AZN AstraZeneca PLC
Total Voting Rights
13:17 01-02-2019 AZN AstraZeneca PLC
Forxiga receives positive EU CHMP opinion
14:00 25-01-2019 AZN AstraZeneca PLC
Completion of divestment of US Synagis rights
13:00 07-01-2019 AZN AstraZeneca PLC
AstraZeneca announces organisational changes
15:00 02-01-2019 AZN AstraZeneca PLC
Total Voting Rights
13:47 20-12-2018 AZN AstraZeneca PLC
Bevespi Aerosphere approved in the EU for COPD
07:05 20-12-2018 AZN AstraZeneca PLC
Lynparza meets primary endpoint in SOLO-3 trial
07:00 20-12-2018 AZN AstraZeneca PLC
Phase III ROCKIES and OLYMPUS roxadustat trials
09:09 18-12-2018 AZN AstraZeneca PLC
Roxadustat approved in China for the treatment of
07:00 14-12-2018 AZN AstraZeneca PLC
Directorate Change
07:00 07-12-2018 AZN AstraZeneca PLC
Update on the Phase III EAGLE trial of Imfinzi
07:00 06-12-2018 AZN AstraZeneca PLC
Divestment of rights to Covis completed
15:00 04-12-2018 AZN AstraZeneca PLC
Director/PDMR Shareholding
16:00 03-12-2018 AZN AstraZeneca PLC
Block listing Interim Review
16:00 03-12-2018 AZN AstraZeneca PLC
Total Voting Rights
07:00 03-12-2018 AZN AstraZeneca PLC
Gr�nenthal Agreement for Nexium, Vimovo Completed
07:00 26-11-2018 AZN AstraZeneca PLC
US FDA grants Fasenra ODD for EGPA
07:00 16-11-2018 AZN AstraZeneca PLC
AstraZeneca provides update on Phase III MYSTIC
07:00 13-11-2018 AZN AstraZeneca PLC
AstraZeneca to divest US Synagis rights to Sobi
07:00 12-11-2018 AZN AstraZeneca PLC
Farxiga significantly reduced hospitalisation for
07:05 12-11-2018 AZN AstraZeneca PLC
US FDA accepts regulatory submission for Lynparza
07:00 08-11-2018 AZN AstraZeneca PLC
AZN: Year-to-Date and Q3 2018 Results
07:00 06-11-2018 AZN AstraZeneca PLC
Divestment of rights to Covis Pharma
15:00 01-11-2018 AZN AstraZeneca PLC
Total Voting Rights
09:45 31-10-2018 AZN AstraZeneca PLC
Additional financial information-Gr�nenthal deal
07:00 30-10-2018 AZN AstraZeneca PLC
Gr�nenthal Agreement for rights to Nexium, Vimovo
07:00 23-10-2018 AZN AstraZeneca PLC
AstraZeneca Extends Innate Pharma Collaboration
07:00 22-10-2018 AZN AstraZeneca PLC
Lynparza shows 70% reduction in PFS ovarian cancer
13:09 19-10-2018 AZN AstraZeneca PLC
CHMP positive opinion Bevespi Aerosphere
07:00 16-10-2018 AZN AstraZeneca PLC
FDA Orphan Drug for Lynparza in pancreatic cancer
15:00 01-10-2018 AZN AstraZeneca PLC
Total Voting Rights
07:00 01-10-2018 AZN AstraZeneca PLC
Atacand Agreement with Cheplapharm Completed
16:00 28-09-2018 AZN AstraZeneca PLC
Previous Announcement Regarding Appointment Of NED
13:15 25-09-2018 AZN AstraZeneca PLC
Overall survival data for Imfinzi: Stage III NSCLC
16:10 24-09-2018 AZN AstraZeneca PLC
EMA approves AZ's Imfinzi for Stage III NSCLC
07:00 24-09-2018 AZN AstraZeneca PLC
Farxiga gets positive result in DECLARE-TIMI 58
07:00 14-09-2018 AZN AstraZeneca PLC
FDA approves AZ's Lumoxiti in hairy cell leukaemia
07:00 07-09-2018 AZN AstraZeneca PLC
Tezepelumab FDA Breakthrough Therapy Designation
07:00 06-09-2018 AZN AstraZeneca PLC
Directorate Change
15:00 03-09-2018 AZN AstraZeneca PLC
Total Voting Rights
07:00 31-08-2018 AZN AstraZeneca PLC
AstraZeneca Update on Anifrolumab in SLE
07:00 30-08-2018 AZN AstraZeneca PLC
EC approves Bydureon BCise device for T2 diabetes
07:00 23-08-2018 AZN AstraZeneca PLC
AstraZeneca PIIIb trial update for Bevespi in COPD
07:00 21-08-2018 AZN AstraZeneca PLC
AZ's Tagrisso approved in Japan for 1st-line NSCLC
07:00 15-08-2018 AZN AstraZeneca PLC
AstraZeneca prices a $3bn bond issue
07:00 03-08-2018 AZN AstraZeneca PLC
EMA grants OD for selumetinib in NF1
15:00 01-08-2018 AZN AstraZeneca PLC
Total Voting Rights
14:00 27-07-2018 AZN AstraZeneca PLC
CHMP recommends Imfinzi for Stage III nsclc
07:00 26-07-2018 AZN AstraZeneca PLC
AZN: H1 2018 Results
07:00 24-07-2018 AZN AstraZeneca PLC
Atacand to be divested to Cheplapharm in Europe
12:00 18-07-2018 AZN AstraZeneca PLC
Holding(s) in Company
15:00 02-07-2018 AZN AstraZeneca PLC
Total Voting Rights
07:00 02-07-2018 AZN AstraZeneca PLC
Lynparza approved in Japan for BRCAm breast cancer
07:00 02-07-2018 AZN AstraZeneca PLC
Imfinzi approved in Japan for Stage III nsclc
15:00 29-06-2018 AZN AstraZeneca PLC
Bydureon receives positive CHMP opinion for BCise
13:30 28-06-2018 AZN AstraZeneca PLC
AZ and Luye Pharma complete agreement for Seroquel
07:00 27-06-2018 AZN AstraZeneca PLC
Lynparza: significant PFS 1st-line ovarian cancer
07:00 26-06-2018 AZN AstraZeneca PLC
Board Committee Changes
07:00 22-06-2018 AZN AstraZeneca PLC
Publication of a Prospectus
07:00 12-06-2018 AZN AstraZeneca PLC
Update: lanabecestat Phase III Alzheimer's trials
17:30 08-06-2018 AZN AstraZeneca PLC
EU APPROVES TAGRISSO FOR 1ST-LINE NSCLC
07:00 08-06-2018 AZN AstraZeneca PLC
Director Declaration
15:00 01-06-2018 AZN AstraZeneca PLC
Block listing Interim Review
15:00 01-06-2018 AZN AstraZeneca PLC
Total Voting Rights
11:00 01-06-2018 AZN AstraZeneca PLC
Director Declaration
07:00 30-05-2018 AZN AstraZeneca PLC
Update on TERRANOVA PIII trial for Fasenra in COPD
07:00 25-05-2018 AZN AstraZeneca PLC
AZ's Imfinzi: significant OS in Stage III nsclc
07:00 21-05-2018 AZN AstraZeneca PLC
AZ regulatory submission in Japan for Forxiga
07:00 21-05-2018 AZN AstraZeneca PLC
US FDA approves Lokelma for adult hyperkalaemia
17:30 18-05-2018 AZN AstraZeneca PLC
Result of AGM
07:00 18-05-2018 AZN AstraZeneca PLC
AZN: Q1 2018 Results
15:00 02-01-2018 AZN AstraZeneca PLC
Total Voting Rights
15:10 10-01-2018 AZN AstraZeneca PLC
AstraZeneca's Fasenra approved in the EU
16:10 12-01-2018 AZN AstraZeneca PLC
FDA approves Lynparza for metastatic breast cancer
07:00 19-01-2018 AZN AstraZeneca PLC
ASTRAZENECA'S FASENRA RECEIVES APPROVAL IN JAPAN
07:00 19-01-2018 AZN AstraZeneca PLC
LYNPARZA APPROVED IN JAPAN FOR OVARIAN CANCER
18:20 26-01-2018 AZN AstraZeneca PLC
AZ Reports Phase III Results for PT010 in COPD
15:00 01-02-2018 AZN AstraZeneca PLC
Total Voting Rights
07:00 02-02-2018 AZN AstraZeneca PLC
AZN: Full-Year 2017 Results
14:00 05-02-2018 AZN AstraZeneca PLC
Director/PDMR Shareholding
07:00 15-02-2018 AZN AstraZeneca PLC
Selumetinib in NF1 gets FDA orphan drug status
07:00 19-02-2018 AZN AstraZeneca PLC
AstraZeneca's IMFINZI approved for Stage III nsclc
12:35 23-02-2018 AZN AstraZeneca PLC
Lynparza CHMP for ovarian cancer maintainance
15:00 01-03-2018 AZN AstraZeneca PLC
Total Voting Rights
11:00 06-03-2018 AZN AstraZeneca PLC
Annual Financial Report
07:00 07-03-2018 AZN AstraZeneca PLC
Filing of Form 20-F with SEC
07:00 12-03-2018 AZN AstraZeneca PLC
ASTRAZENECA UPDATES MYSTIC TRIAL TIMELINE
16:48 22-03-2018 AZN AstraZeneca PLC
Lokelma approved in the EU
15:00 26-03-2018 AZN AstraZeneca PLC
Director/PDMR Shareholding
15:00 28-03-2018 AZN AstraZeneca PLC
Director/PDMR Shareholding
15:00 03-04-2018 AZN AstraZeneca PLC
Total Voting Rights
07:00 03-04-2018 AZN AstraZeneca PLC
AZ AND MSD SUBMIT LYNPARZA FOR BREAST CANCER IN EU
07:00 03-04-2018 AZN AstraZeneca PLC
FDA TO REVIEW MOXETUMOMAB FOR HAIRY CELL LEUKAEMIA
07:00 05-04-2018 AZN AstraZeneca PLC
Directorate Change
11:00 13-04-2018 AZN AstraZeneca PLC
Notice of AGM
07:00 19-04-2018 AZN AstraZeneca PLC
FDA approves Tagrisso for 1st-line use in NSCLC
07:00 24-04-2018 AZN AstraZeneca PLC
AstraZeneca:high level results of the ARCTIC trial
12:30 27-04-2018 AZN AstraZeneca PLC
AZ: positive CHMP for Tagrisso first-line nsclc
15:00 01-05-2018 AZN AstraZeneca PLC
Total Voting Rights
12:00 04-05-2018 AZN AstraZeneca PLC
Director Declaration
11:00 08-05-2018 AZN AstraZeneca PLC
EMA approves Lynparza: maintenance ovarian cancer
07:00 08-05-2018 AZN AstraZeneca PLC
AZ and Luye Pharma enter agreement for Seroquel
07:00 11-05-2018 AZN AstraZeneca PLC
AstraZeneca update on Fasenra PIII trial in COPD